Genzyme plant up and running again

Genzyme resumed production of Cerezyme, its drug for Gaucher's disease, after contamination problems forced the company to stop manufacturing the drug for a month. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.